Successful risk stratification of a patient with ventricular preexcitation by improved transesophageal electrophysiological study.
Qin C, He T, Li S.
Ann Noninvasive Electrocardiol. 2021 Sep;26(5):e12882. doi: 10.1111/anec.12882. Epub 2021 Jul 21.
Hyperleptinemia Exacerbates High-Fat Diet-Mediated Atrial Fibrosis and Fibrillation.
Fukui A, Ikebe-Ebata Y, Kondo H, Saito S, Aoki K, Fukunaga N, Shinohara T, Masaki T, Teshima Y, Takahashi N.
J Cardiovasc Electrophysiol. 2017 Jun;28(6):702-710. doi: 10.1111/jce.13200. Epub 2017 May 2.
Association between atrial septal aneurysm and arrhythmias.
Yetkin E, Ileri M, Korkmaz A, Ozturk S.
Scand Cardiovasc J. 2020 Jun;54(3):169-173. doi: 10.1080/14017431.2019.1667525. Epub 2019 Sep 23.
Prominent crista terminalis mimicking a right atrial mass: a systematic literature review and meta-analysis.
Matusik PS, Mikrut K, Bryll A, Podolec M, Popiela TJ, Matusik PT.
Acta Radiol. 2024 Jun;65(6):588-600. doi: 10.1177/02841851241242461. Epub 2024 Apr 15.
Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.
Fukui A, Takahashi N, Nakada C, Masaki T, Kume O, Shinohara T, Teshima Y, Hara M, Saikawa T.
Circ Arrhythm Electrophysiol. 2013 Apr;6(2):402-9. doi: 10.1161/CIRCEP.111.000104. Epub 2013 Feb 13.
Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study.
Han Y, Shao M, Yang H, Sun H, Sang W, Wang L, Wang L, Yang S, Jian Y, Tang B, Li Y.
Sci Rep. 2024 Mar 11;14(1):5926. doi: 10.1038/s41598-024-56651-9.
Heart rate variability parameters in children with ventricular preexcitation.
Koca S, Pac FA, Mihcioglu A, Eris D, Cay S, Ozeke O.
J Cardiovasc Electrophysiol. 2018 Aug;29(8):1135-1142. doi: 10.1111/jce.13613. Epub 2018 May 10.
Feasibility and safety of pulsed field ablation at the ventricular outflow tract using focal point catheter.
Zheng L, Maimaitijiang P, Chen A, Lai Z, Yao Y.
Heart Rhythm. 2024 Nov 1:S1547-5271(24)03520-3. doi: 10.1016/j.hrthm.2024.10.059. Online ahead of print.
Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
Kuhn H, Gietzen FH, Leuner C, Schäfers M, Schober O, Strunk-Müller C, Obergassel L, Freick M, Gockel B, Lieder F, Raute-Kreinsen U.
Z Kardiol. 2000;89 Suppl 4:IV41-54. doi: 10.1007/s003920070062.
Wide-complex tachycardias. The importance of identifying the mechanism.
Janeira LF.
Postgrad Med. 1996 Sep;100(3):259-62, 265-6, 269-72 passim. doi: 10.3810/pgm.1996.09.81.
